Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,651 | 202 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $706.35 | 34 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $659.45 | 31 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $393.70 | 30 | $0 (2024) |
| Oyster Point Pharma, Inc. | $338.31 | 23 | $0 (2024) |
| Alcon Vision LLC | $301.18 | 15 | $0 (2024) |
| Shire North American Group Inc | $200.09 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $176.63 | 12 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $148.13 | 9 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $78.73 | 2 | $0 (2022) |
| Allergan, Inc. | $76.11 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,256 | 70 | Regeneron Healthcare Solutions, Inc. ($327.92) |
| 2023 | $1,024 | 57 | Regeneron Healthcare Solutions, Inc. ($258.99) |
| 2022 | $597.23 | 28 | ABBVIE INC. ($146.53) |
| 2021 | $176.67 | 12 | Allergan, Inc. ($44.76) |
| 2020 | $14.58 | 1 | Regeneron Healthcare Solutions, Inc. ($14.58) |
| 2019 | $199.11 | 12 | Alcon Vision LLC ($64.51) |
| 2018 | $141.31 | 9 | Novartis Pharmaceuticals Corporation ($66.39) |
| 2017 | $241.97 | 13 | Shire North American Group Inc ($105.32) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: EYE CARE | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: EYE CARE | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Dry eyes | ||||||
| 11/13/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/06/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: EYE CARE | ||||||
| 11/01/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Dry eyes | ||||||
| 10/30/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: EYE CARE | ||||||
| 10/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: EYE CARE | ||||||
| 10/24/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: EYE CARE | ||||||
| 10/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Dry eyes | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Dry eyes | ||||||
| 09/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: EYE CARE | ||||||
| 09/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: EYE CARE | ||||||
| 09/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,211 | 3,085 | $1.5M | $340,065 |
| 2022 | 12 | 2,356 | 3,167 | $1.6M | $354,417 |
| 2021 | 12 | 2,588 | 3,394 | $1.6M | $394,582 |
| 2020 | 10 | 2,029 | 2,787 | $1.3M | $338,148 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 234 | 502 | $1.1M | $173,981 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 865 | 1,216 | $115,520 | $78,095 | 67.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 52 | 73 | $61,320 | $19,597 | 32.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 188 | 188 | $26,320 | $16,006 | 60.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $31,020 | $15,251 | 49.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 247 | 425 | $76,500 | $12,782 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 123 | $21,450 | $10,986 | 51.2% |
| 92134 | Imaging of retina | Office | 2023 | 167 | 189 | $14,175 | $5,782 | 40.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 138 | 164 | $12,300 | $4,289 | 34.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 28 | 34 | $3,400 | $1,613 | 47.4% |
| 11440 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 13 | 14 | $5,280 | $1,553 | 29.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 16 | 16 | $1,200 | $128.62 | 10.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 245 | 518 | $1.2M | $174,815 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 767 | 1,064 | $101,080 | $66,886 | 66.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 69 | 92 | $78,120 | $25,198 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 173 | 173 | $38,060 | $18,977 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 189 | $28,350 | $15,590 | 55.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 250 | 407 | $73,260 | $13,288 | 18.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 112 | 112 | $19,040 | $11,653 | 61.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 130 | 134 | $16,080 | $8,553 | 53.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 106 | 106 | $14,840 | $8,397 | 56.6% |
| 92134 | Imaging of retina | Office | 2022 | 164 | 191 | $14,325 | $5,880 | 41.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 125 | 152 | $11,400 | $3,875 | 34.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 28 | 29 | $2,900 | $1,305 | 45.0% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 229 | 497 | $1.1M | $164,851 | 15.3% |
About Dr. Michael Malstrom, MD
Dr. Michael Malstrom, MD is a Ophthalmology healthcare provider based in Pottstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386862316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Malstrom, MD has received a total of $3,651 in payments from pharmaceutical and medical device companies, with $1,256 received in 2024. These payments were reported across 202 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,651).
As a Medicare-enrolled provider, Malstrom has provided services to 9,184 Medicare beneficiaries, totaling 12,433 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Pottstown, PA
- Active Since 04/23/2007
- Last Updated 07/26/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1386862316
Products in Payments
- EYLEA HD (Biological) $503.19
- DURYSTA (Drug) $376.13
- TYRVAYA (Drug) $338.31
- XIIDRA (Drug) $290.19
- OZURDEX (Drug) $226.41
- VYZULTA (Drug) $216.45
- EYLEA (Biological) $156.26
- XIPERE (Drug) $137.12
- AcrySof (Device) $109.59
- LUMIGAN (Drug) $107.06
- Cequa (Drug) $99.71
- YUTIQ (Drug) $78.73
- ARGOS (Device) $65.50
- Simbrinza (Drug) $62.05
- VUITY (Drug) $59.67
- Cimerli (Biological) $54.84
- Omidria (Drug) $50.69
- Vabysmo (Drug) $46.12
- Xeomin (Biological) $38.52
- Rocklatan (Drug) $37.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.